Vincent Bodenant

Vincent Bodenant is an experienced pharmaceutical professional with expertise in research and development, particularly in SPECT and PET products. Currently serving as R&D Director at Curium Pharma since February 2016, Vincent manages three teams focused on development and analytical processes. Previously, as CMC PET Director, Vincent oversaw a team dedicated to the development and analytical aspects of PET products. Vincent's career includes a role as CMC Pharmacist at IBA Molecular, where responsibilities included analytical development and operations transfer in Europe. At CIS Bio International, Vincent contributed as an R&D Pharmacist and interim scientific editor, specializing in module 3 documentation and pharmaceutical development processes. Vincent holds a degree in Pharmacy from Université Paris Cité.